# Phase II Study of AP0302 5% Versus a Vehicle Comparator

> **NCT02324985** · PHASE2 · COMPLETED · sponsor: **Aponia Laboratories, Inc.** · enrollment: 147 (actual)

## Conditions studied

- Pain
- Delayed Onset Muscle Soreness

## Interventions

- **DRUG:** S-Ibuprofen Topical Gel 5%
- **DRUG:** Vehicle Topical Gel

## Key facts

- **NCT ID:** NCT02324985
- **Lead sponsor:** Aponia Laboratories, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2015-07
- **Final completion:** 2016-06
- **Target enrollment:** 147 (ACTUAL)
- **Last updated:** 2019-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02324985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02324985, "Phase II Study of AP0302 5% Versus a Vehicle Comparator". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02324985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*